SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-17-000039
Filing Date
2017-08-07
Accepted
2017-08-07 07:11:44
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a6301710qaxovant.htm 10-Q 834866
2 EXHIBIT 31.1 a63017exhibit311.htm EX-31.1 10093
3 EXHIBIT 31.2 a63017exhibit312.htm EX-31.2 10026
4 EXHIBIT 32.1 a63017exhibit321.htm EX-32.1 6319
5 EXHIBIT 32.2 a63017exhibit322.htm EX-32.2 6301
  Complete submission text file 0001636050-17-000039.txt   2678777

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20170630.xml EX-101.INS 249684
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20170630.xsd EX-101.SCH 24837
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20170630_cal.xml EX-101.CAL 43162
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20170630_def.xml EX-101.DEF 108160
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20170630_lab.xml EX-101.LAB 334107
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20170630_pre.xml EX-101.PRE 188556
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 171009971
SIC: 2834 Pharmaceutical Preparations